ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,150, issued on March 31, was assigned to GENMAB A/S (Valby, Denmark).
"Antibodies binding AXL" was invented by Esther Breij (Utrecht, Netherlands), David Satijn (Utrecht, Netherlands), Edward Norbert Van Den Brink (Halfweg, Netherlands), Dennis Verzijl (Amstelveen, Netherlands), Rob N. De Jong (Utrecht, Netherlands), Paul Parren (Odijk, Netherlands) and Riemke Van Dijkhuizen Radersma (Zeist, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions."
The patent was ...